万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
2-8℃
- 保质期:
见包装
- 英文名:
Danshensu
- 库存:
大量现货
- 供应商:
上海研谨生物
- CAS号:
76822-21-4
- 规格:
20mg
丹参素
分析标准品,HPLC≥98%
Danshensu
CAS号:76822-21-4
分子式:C9H10O5
分子量:198.17
MDL:MFCD07781415
|
货号 |
规格/参数/品牌 |
价格 |
货期 |
|
YJ-B20254-20mg |
分析标准品,HPLC≥98% |
¥500.00 |
现货 |
|
YJ-B20254-200mg |
分析标准品,HPLC≥98% |
¥2860.00 |
现货 |
|
JS31458-1g |
≥98% |
¥1300.00 |
现货 |
|
JS31458-10g |
≥98% |
¥4600.00 |
现货 |
产品介绍
熔点:84-86℃
沸点:481.5 ℃ at 760 mmHg
比旋光度:+11.5°(甲醇)
外观:白色长针状结晶
溶解性:可溶于水及常见的有机溶剂中,如甲醇、乙醇、丙tong、乙mi等。
储存条件:2-8℃
注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验参考文献(46篇)
46. [IF=3.4] Wang Qiaona et al."Anti-oxidative effect of Salvia miltiorrhiza Bunge fermented with Shiraia bambusicola Henn. against H2O2-induced injury in PC12 cells."BMC Complementary Medicine and Therapies.2025 Dec;25(1):1-13
45. [IF=4] Lijuan Wu et al."Integration of chromatographic fractionation, quantitative 1H-NMR and serially coupled achiral-chiral LC–MS/MS enables multi-components-targeted determination of Salvia miltiorrhiza in an authentic compound-independent manner."JOURNAL OF
44. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253
43. [IF=3.8] Liping Zhang et al."Comprehensive characterization of active components in Salvia miltiorrhiza using polarity-partitioned two-dimensional liquid chromatography coupled with mass spectrometry."JOURNAL OF CHROMATOGRAPHY A.2024 Oct;:465424
42. [IF=1.5] Huijuan Tao et al."Danshensu and Notoginsenoside R1 Combination Alleviates Obesity in Mice Via Modification of Gut Microbiota and Short-Chain Fatty Acids."Natural Product Communications.;():
41. [IF=5.7] Yue Wang et al."Precise Molecularly Imprinted Montmorillonite for Selective Adsorption of Salvianolic Acid A with Ultra-large Capacity."Surfaces and Interfaces.2025 Jan;:105741
40. [IF=5.3] Yao Chen et al."Biomimetic metal-phenolic nanocarrier for co-delivery of multiple phytomedical bioactive components for anti-atherosclerotic therapy."INTERNATIONAL JOURNAL OF PHARMACEUTICS.2025 Jan;:125228
39. [IF=4.8] Chuang Li et al."Integrative analyzing the molecular basis of Clerodendranthus Spicatus aqueous extract in hyperuricemia nephropathy via network pharmacology and experimental validation."Food Bioscience.2025 Feb;:106152
38. [IF=4.7] Yule Wang et al."Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization."Drug Design Development and Therapy.
37. [IF=4.8] Qingquan Li et al."Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jan;336:118743
36. [IF=4.8] Ze-Yu Zhang et al."Mechanism of action of the Banxia–Xiakucao herb pair in sleep deprivation: New comprehensive evidence from network pharmacology, transcriptomics and molecular biology experiments."JOURNAL OF ETHNOPHARMACOLOGY.2024 Nov;334:118534
35. [IF=1.1] Ji-Yong FU et al."Simultaneous determination of 19 constituents in the Jian-Nao-Ning mixture using high-performance liquid chromatography-tandem mass spectrometry."Separation Science Plus".2024 Feb;:2300222
34. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692
33. [IF=3.4] Jia Sun et al."Analysis of compatibility mechanism of shenxiong glucose injection after multiple dosing based on differences of PK-PD correlation and cytochrome P450 enzyme."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115899
32. [IF=4.9] Qingfa Tang et al."ROS-Responsive Prodrug Micelle Co-Delivery System for Synergistic Antiatherosclerotic Therapy."MOLECULAR PHARMACEUTICS.2023;XXXX(XXX):XXX-XXX
31. [IF=3.318] Jun-Ming Li et al."A sensitive LC-MS/MS method-based pharmacokinetic study of fifteen active ingredients of Yindan Xinnaotong soft capsule in rats and its potential mechanism in the treatment of cardiovascular diseases."JOURNAL OF CHROMATOGRAPHY B-ANALYTI
30. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396
29. [IF=4.927] Jinyang Fang et al."Discovery of Natural Small Molecules Promoting Collagen Secretion by High-Throughput Screening in Caenorhabditis elegans."MOLECULES.2022 Jan;27(23):8361
28. [IF=4.927] Ke Shun Hu et al."Production of Salvianic Acid A from l-DOPA via Biocatalytic Cascade Reactions."MOLECULES.2022 Jan;27(18):6088
27. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy.
26. [IF=6.627] Jiadong Hu et al."Identification of Abietane-Type Diterpenoids and Phenolic Acids Biosynthesis Genes in Salvia apiana Jepson Through Full-Length Transcriptomic and Metabolomic Profiling."Frontiers in Plant Science.2022; 13: 919025
25. [IF=9.078] Jun Qian et al."A strategy for effective recovery of salvianolic acid a from Salvia miltiorrhiza (Danshen) through multiple interactions."Compos Part B-Eng. 2022 Feb;231:109563
24. [IF=6.057] Qi Tong et al.Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.Talanta. 2021 Nov;:123045
23. [IF=3.512] Yahong Chen et al."Identification of Potential Human Ryanodine Receptor 1 Agonists and Molecular Mechanisms of Natural Small-Molecule Phenols as Anxiolytics."Acs Omega. 2021;XXXX(XXX):XXX-XXX
22. [IF=4.36] Jing Chen et al."Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling."J Ethnopharmacol. 2021 Sep;:114667
21. [IF=4.759] Yi Zhang et al."Screening of inhibitors against histone demethylation jumonji domain-containing protein 3 by capillary electrophoresis."J Chromatogr A. 2020 Feb;1613:460625
20. [IF=5.81] Jun Li et al."Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish."Front Pharmacol. 2020; 11: 622787
19. [IF=5.81] Chenning Zhang et al."Global Analysis the Potential Medicinal Substances of Shuangxia Decoction and the Process In Vivo via Mass Spectrometry Technology."Front Pharmacol. 2021; 12: 654807
18. [IF=6.475] Shi Qiu et al."Selection of appropriate post-harvest processing methods based on the metabolomics analysis of Salvia miltiorrhiza Bunge."Food Res Int. 2021 Jun;144:110366
17. [IF=3.049] Jixia Wang et al."Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay."Rsc Adv. 2015 Mar;5(33):25768-25776
16. Wang, Jixia, et al. "Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay." RSC Advances 5.33 (2015): 25768-25776.https:##doi.org/10.1039/C4RA16102E
15. Li J, Liu H, Yang Z, Yu Q, Zhao L, Wang Y. Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish. Front Pharmacol. 2021;11:622787. Published 2021 Jan 14. doi:10.3389/fphar.2020.6
14. Cheng, Yan, et al. "Decomposition of five phenolic compounds in high temperature water." Journal of the Brazilian Chemical Society 25 (2014): 2102-2107.https:##doi.org/10.5935/0103-5053.20140201
13. 黑小斌,李欢,李慧,梁小燕,高静,彭亮,李依民,张岗.丹参无菌培养体系构建及有效成分含量的HPLC分析[J].中草药,2020,51(22):5833-5838.
12. 李清清 张继芬. 冠心宁中14种成分的含量测定[J]. 苏盐科技 2019 046(006):33-35.
11. 支旭然 刘洪涛 吴茵 等. UPLC-MS/MS法同时测定肾康注射液中7个有效成分[J]. 药物分析杂志 2017 037(001):37-42.
10. 黄娟, 丘小惠, 白俊其,等. 根茎类药材丹参精准煮散饮片的质量评价[J]. 中国实验方剂学杂志, 2017, 023(011):18-22.
9. 支旭然 董占军 吴茵 等. HPLC同时测定肾康注射液中的4种成分[J]. 华西药学杂志 2017(03):297-299.
8. 崔伟亮 李慧芬 张学兰 等. UPLC-QE/MS法分析丹参酒炙前后5种质变化合物[J]. 中成药 2019 041(004):844-849.
7. 周惠芬 何昱 艾进超 等. 丹红注射液主要有效成分配伍在脑缺血再灌注大鼠体内的药动学研究[J]. 中草药 2016(20).
6. 梁琨 孙辉 安叡 等. LC-MS/MS法同时测定护心口服液中11种成分[J]. 中成药 2018 040(001):105-109.
5. 唐一梅, 高苏亚, 张彦,等. 离子液体辅助提取丹参中丹参素的工艺条件及机理[J]. 化工科技, 2018, 026(003):42-46.
4. 王红玉, 李晶晶, 周莹,等. 欣梦颗粒中丹参素在大鼠体内的药动学研究[J]. 中药新药与临床药理, 2017(4).
3. 陈钱 林慧 于敬伟 等. 丹参素在体外条件下对口腔鳞癌细胞CAL-27抑制作用的研究[J]. 口腔医学 2019 039(002):113-116.
2. 叶凤 曹文富.丹参含药血清调节大鼠肝星状细胞TGF-β1及细胞周期素CyclinD1的机制研究[J].重庆医科大学学报 2016 41(04):369-373.
1. 范红晶 刘晨敏 杨洁红 等. 丹参中丹参素的提取工艺优化研究[J]. 中华中医药学刊 2016 v.34(04):782-784.
【摘要】 目的:建立一种测定心舒颗粒含量的方法。方法:以Shim�pack CLC�ODS(5 μm,4.6 mm×150 mm)为分析柱,甲醇�乙腈�磷酸三乙胺水溶液(4:3:93)为流动相,检测波长281 nm,进样量10 μL。采用HPLC法测定丹参素钠的含量。结果:丹参素钠在0.26 μg-0.62 μg范围内,线性关系:Y=14372866X-137054.2(r=0.9998),平均回收率为97.32%,RSD=1.66%(n=5)。结论:本法操作简便,结果可靠,重现
、准确,具有实用性,可作为近视康合剂的质量控制标准。 【关键词】 近视康合剂;原儿茶醛;芍药苷;薄层色谱法;高效液相色谱法 近视康合剂是我院应用多年的纯中药复方制剂,由丹参、当归、白芍等十二味中药组成,具有养血活血、疏肝健脾、升阳明目的作用。用于假性近视及弱视的恢复治疗,疗效显著,不良反应少。方中丹参为君药,它的活性成分有脂溶性菲醌类衍生物和水溶性酚酸类,水溶性酚酸类成分包括原儿茶醛、丹参素、原儿茶酸、丹酚酸A、B、C等。丹参制剂的质量控制标准不尽统一[1�7]。近视康合剂
技术资料暂无技术资料 索取技术资料










